Selinexor Treatment of Refractory Myeloma

Clinical trial NCT02336815 · COMPLETED

Trial details

NCT number: NCT02336815
Sponsor: Karyopharm Therapeutics Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2015-05-26
Primary completion: 2019-07-26
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.